Lactoferrin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Function (Iron Absorption, Anti-inflammatory, Intestinal Flora Protection, Antibacterial, Immune Cell Stimulation, Antioxidant), By Application (Food & Beverages, Infant Formula, Sports & Functional Foods, Pharmaceuticals, Personal Care Products, Animal Feed), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 148.39 Million
CAGR (2026-2031)	9.02%
Fastest Growing Segment	Infant Formula
Largest Market	Asia Pacific
Market Size (2031)	USD 249.14 Million

Market Overview

The Global Lactoferrin Market is projected to grow from USD 148.39 Million in 2025 to USD 249.14 Million by 2031 at a 9.02% CAGR. Lactoferrin, an 80 kDa iron-binding glycoprotein naturally present in mammalian milk and various secretory fluids, is recognized for its broad spectrum of biological activities including antimicrobial, antiviral, anti-inflammatory, and immunomodulatory properties. The market for lactoferrin is primarily driven by increasing consumer awareness regarding its health benefits, particularly in boosting immunity and enhancing iron absorption. Furthermore, expanding applications in infant nutrition, where it mimics breast milk components, along with growing utilization in functional foods, dietary supplements, and pharmaceuticals, significantly support market expansion.

Despite these drivers, the global lactoferrin market faces a notable challenge in the high production costs associated with its extraction and purification from natural sources. This intricate process requires specialized technology, limiting affordability and scalability. According to the USDA Foreign Agricultural Service, New Zealand's fluid milk production was estimated at 21.7 million metric tons in the 2025 market year, with a considerable portion directed towards value-added dairy derivatives such as lactoferrin, underscoring the raw material intensity of its production.

Key Market Drivers

The increasing consumer awareness of lactoferrin's health benefits profoundly impacts the market by fostering demand for immune-supporting and nutritionally enhanced products. This heightened consumer focus on preventive healthcare and ingredient quality is evident as companies respond with products leveraging lactoferrin's proven properties. For instance, according to FrieslandCampina Ingredients in January 2025, over 59% of parents with children under one year expressed a desire to support their child's immunity, directly influencing the inclusion of such beneficial components in nutritional offerings. This robust consumer interest expands beyond traditional supplements into functional foods and beverages, broadening lactoferrin's application base.

The rising demand for lactoferrin in infant formula constitutes another critical market driver, stemming from its ability to mimic breast milk components and support infant immunity and iron absorption. This has prompted significant industry investments in production and innovation. According to Mejerimedier in September 2024, Arla Foods is expanding its HOCO plant in Holstebro, Denmark, with a new factory expected to increase powder production by approximately 180 kg per day, specifically scaling up lactoferrin eluate production, with construction beginning in 2025. Such expansions underscore the imperative to meet growing global requirements for lactoferrin in early life nutrition. Reflecting broader market confidence, Agronomics, a cellular agriculture investor, invested a further AUD 3 million into Australian biotech All G in January 2026, as part of a wider AUD 10 million funding round, to support the scale-up of lactoferrin produced via precision fermentation.

Download Free Sample Report

Key Market Challenges

The challenge of high production costs significantly hinders the global lactoferrin market. The intricate processes involved in extracting and purifying lactoferrin from natural sources, primarily mammalian milk, necessitate specialized technology and substantial investment. This directly impacts the affordability of lactoferrin-based products, making them less accessible to a broader consumer base and limiting their market penetration, particularly in price-sensitive segments. Furthermore, the specialized nature of these extraction methods restricts scalability, as expanding production requires considerable capital expenditure and advanced infrastructure. According to the International Dairy Federation's 2025 World Dairy Situation Report, global production of unprocessed milk (all species) rose by 2.2% in 2024. While this indicates a growing raw material base, the inherent complexities and costs of isolating a high-purity ingredient like lactoferrin from this volume continue to pose a significant barrier to achieving more economical large-scale production, thereby impeding overall market expansion.

Key Market Trends

The integration of lactoferrin into cosmeceutical and personal care products represents a significant market trend, driven by increasing scientific understanding of its diverse biological activities. As research continues to uncover lactoferrin's antimicrobial, anti-inflammatory, and antioxidant properties, its appeal as an active ingredient in skincare, haircare, and oral care formulations is growing. Manufacturers are exploring its potential to address various skin concerns, from acne to anti-aging, leveraging its natural origins and multifaceted benefits. According to the official website of Morinaga Milk Industry, updated as of December 2025, over 9,000 scientific papers on lactoferrin have been published globally, highlighting its diverse properties and applications beyond traditional nutrition, which underpins this expansion into new health and beauty categories.

Concurrently, the growth in demand for animal-free lactoferrin is reshaping the market, propelled by consumer preferences for sustainable, ethical, and allergen-friendly ingredients. Precision fermentation technology is pivotal in enabling the production of lactoferrin without animal input, offering a scalable and consistent alternative to traditional bovine-derived sources. This trend is opening new market segments and attracting investment as companies seek to meet the evolving dietary and ethical choices of consumers. For instance, according to FoodNavigator-USA, January 6, 2025, in the article 'Is the US market ready for precision-fermented lactoferrin?', Strive Nutrition was expected to launch a functional beverage and a ready-to-mix protein powder containing TurtleTree's animal-free lactoferrin in Q1 2025, signaling the commercial viability and market acceptance of such innovative products.

Segmental Insights

The infant formula segment represents the fastest-growing and dominant application within the Global Lactoferrin Market. This rapid expansion is primarily driven by lactoferrin's natural presence in human breast milk, where it offers crucial immune-boosting, antimicrobial, and iron absorption benefits for infants. Manufacturers are increasingly incorporating lactoferrin into formula products to closely replicate breast milk's nutritional profile, thereby enhancing nutritional value and supporting infant health, particularly in terms of immunity and gut development. Furthermore, growing consumer awareness regarding advanced infant nutrition and supportive regulatory actions, such as the achievement of Generally Recognized as Safe (GRAS) status from the U.S. Food and Drug Administration (FDA) for specific lactoferrin ingredients, significantly contribute to this escalating demand.

Regional Insights

Asia Pacific stands as the leading region in the Global Lactoferrin Market, driven by a combination of demographic and economic factors. The extensive population and high birth rates across countries such as China and India significantly bolster demand for infant formula, where lactoferrin is widely incorporated to mimic the immune-boosting properties of breast milk. Furthermore, growing consumer awareness of lactoferrin's health benefits, including immune system support and gut health improvement, combined with increasing disposable incomes in developing economies, fuels greater adoption of functional foods and dietary supplements. A robust regional dairy industry also ensures a steady source for lactoferrin production, further strengthening market dominance.

Recent Developments

• In April 2026, Pinnacle Food Group, a Canadian biotech firm, announced a significant breakthrough in the cost-effective production of recombinant human lactoferrin. The company developed a methanol-free precision fermentation process at its Hong Kong laboratory, which marked a notable advancement in its research and development pipeline. This innovative method is expected to substantially reduce production expenses and mitigate manufacturing bottlenecks. The breakthrough aims to facilitate wider, high-purity applications for human lactoferrin, which is a key ingredient in areas such as infant nutrition and functional foods, by improving its overall accessibility.
• In April 2026, Australian startup All G achieved a critical regulatory milestone by receiving a "no questions" letter from the US Food and Drug Administration (FDA) for its precision-fermented lactoferrin ingredient, LFX. This official confirmation, following the company's prior self-affirmation of GRAS status, cleared the path for commercial distribution of the cow-free lactoferrin protein in the American market within a few months. The approval supports the ingredient's use across a wide array of food and beverage applications, including functional foods, nutritional products, and dietary supplements, opening up new formats for immune and iron support products.
• In February 2026, Vivici, a Dutch ingredients company, launched its precision-fermented lactoferrin ingredient, Vivitein™ LF, in the United States market. This new product was introduced to address the historical challenges of scarcity and high cost associated with traditionally sourced lactoferrin. Vivitein™ LF achieved self-affirmed Generally Recognized as Safe (GRAS) status in the US, allowing for its application in various nutritional innovations. The company positioned this launch as a significant step towards making lactoferrin more commercially accessible for formulators developing next-generation health and wellness products, supporting functions like iron regulation and gut health.
• In December 2025, Australian biotech company All G and French bioactives leader Armor Protéines established a joint venture to enhance the production and commercialization of both human and bovine lactoferrin. The collaboration leveraged All G's precision fermentation platform with Armor Protéines' expertise in functional milk proteins. This initiative aimed to scale the availability of lactoferrin for applications in infant nutrition, nutraceuticals, personal care, and therapeutics. All G also successfully completed a convertible note round, securing over A$10 million to support commercial-scale production. The first recombinant bovine lactoferrin product was scheduled for launch in late 2025, with human lactoferrin following in early 2026.

Key Market Players

• Hilmar Cheese Co Inc
• Pharming Group NV
• Royal FrieslandCampina N.V.
• Synlait Milk Ltd
• Ingredia SA
• MP Biomedicals LLC
• Tatura Milk Industries Ltd
• Glanbia PLC
• APS BioGroup Inc
• ProHealth Care Inc

By Function	By Application	By Region
Iron Absorption Anti-inflammatory Intestinal Flora Protection Antibacterial Immune Cell Stimulation Antioxidant	Food & Beverages Infant Formula Sports & Functional Foods Pharmaceuticals Personal Care Products Animal Feed	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Lactoferrin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Lactoferrin Market, By Function:

• Iron Absorption
• Anti-inflammatory
• Intestinal Flora Protection
• Antibacterial
• Immune Cell Stimulation
• Antioxidant

• Lactoferrin Market, By Application:

• Food & Beverages
• Infant Formula
• Sports & Functional Foods
• Pharmaceuticals
• Personal Care Products
• Animal Feed

• Lactoferrin Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE